Leflunomide in Previously Treated Metastatic Triple Negative Cancers
Icahn School of Medicine at Mount Sinai
Icahn School of Medicine at Mount Sinai
Incepta Pharmaceuticals Ltd
Ostergotland County Council, Sweden
Endeavor Health
Universitätsmedizin Mannheim
Hoffmann-La Roche
Stanford University
State University of New York - Upstate Medical University
University of Chicago
Novartis
pfm medical gmbh
B.P. Koirala Institute of Health Sciences
Albert Einstein Healthcare Network
Medipol University
Fondation Hôpital Saint-Joseph
University of Rome Tor Vergata
TaiHao Medical Inc.
BioNumerik Pharmaceuticals, Inc.
Syndax Pharmaceuticals
NSABP Foundation Inc
M.D. Anderson Cancer Center
Syndax Pharmaceuticals
Syndax Pharmaceuticals
Syndax Pharmaceuticals
University of Illinois at Chicago
Uppsala University
Medipol University
Novartis
Kanuni Sultan Suleyman Training and Research Hospital
Envision Healthcare Scientific Intelligence, Inc.
National Institutes of Health Clinical Center (CC)
Mayo Clinic
Novartis
Mater Misericordiae University Hospital
Instituto Nacional de Cancer, Brazil
Swedish Medical Center
University of Kansas Medical Center
Merck Sharp & Dohme LLC
University College, London
Assistance Publique - Hôpitaux de Paris
Sysmex America, Inc.
Sysmex America, Inc.
Faculdade de Medicina do ABC